Viewing Study NCT02228850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-05-04 @ 9:56 PM
Study NCT ID: NCT02228850
Status: COMPLETED
Last Update Posted: 2016-03-22
First Post: 2014-08-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Sponsor: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Raynaud's Phenomenon Secondary to Systemic Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Secondary Raynaud's Phenomenon View
None Secondary Raynaud's Disease View
None Scleroderma View
None Raynaud's Disease secondary to systemic sclerosis View
None CREST View
None Apricus Biosciences View
None laser doppler View
None thermography View